1. Home
  2. TENX vs FORA Comparison

TENX vs FORA Comparison

Compare TENX & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$10.84

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Logo Forian Inc.

FORA

Forian Inc.

N/A

Current Price

$2.09

Market Cap

66.2M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
TENX
FORA
Founded
1967
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
56.2M
66.2M
IPO Year
2001
2020

Fundamental Metrics

Financial Performance
Metric
TENX
FORA
Price
$10.84
$2.09
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$22.50
N/A
AVG Volume (30 Days)
181.5K
18.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
96.30
N/A
EPS
N/A
N/A
Revenue
N/A
$20,153,263.00
Revenue This Year
N/A
$51.82
Revenue Next Year
N/A
$7.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.64
$1.64
52 Week High
$18.38
$2.71

Technical Indicators

Market Signals
Indicator
TENX
FORA
Relative Strength Index (RSI) 36.33 45.63
Support Level $5.99 $2.05
Resistance Level $14.15 $2.12
Average True Range (ATR) 0.83 0.02
MACD -0.09 0.00
Stochastic Oscillator 2.33 40.00

Price Performance

Historical Comparison
TENX
FORA

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

About FORA Forian Inc.

Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.

Share on Social Networks: